This is a federal contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of pharmaceutical products, medical supplies, and healthcare equipment. The award, identified as SPE2DB24D8001, is an Indefinite Delivery Contract (IDC) valued at $999,999,999.00 with a performance period extending through December 31, 2025.
The contract is part of the DLA Troop Support Medical's ECAT Generation V Program, which allows Dakota Drug, Inc. to provide a comprehensive range of medical items to support U.S. Armed Forces medical operations. This includes the delivery of various prescription medications, medical devices, vaccines, and healthcare-related supplies such as insulin pens, auto-injectors, inhalers, and tablet/capsule medications. The contract is not set aside and is considered an unrestricted award, indicating Dakota Drug, Inc.'s competitive standing in the federal marketplace.
Generated 3/19/25, 9:58 AM